Ammonium pyrrolidine dithiocarbamate and RS 102895 attenuate opioid withdrawal in vivo and in vitro

Psychopharmacology

Volumn 220, Issue 2, 2012, Pages 427-438

  Rehni, Ashish K ^a   Singh, Nirmal ^a  

^a PUNJABI UNIVERSITY   (India)

Author keywords

C C chemokine receptor 2; Morphine dependence; Nuclear factor kappa beta; Withdrawal syndrome

Indexed keywords

CHEMOKINE RECEPTOR ANTAGONIST; CHEMOKINE RECEPTOR CCR2; I KAPPA B; MORPHINE; PYRROLIDINE DITHIOCARBAMATE; RS 102895; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CIRCLING BEHAVIOR; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; JUMPING; LICKING; LOW DRUG DOSE; MALE; MORPHINE ADDICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REARING; WITHDRAWAL SYNDROME;

ANIMALS; BENZOXAZINES; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FEMALE; ILEUM; MALE; MICE; MORPHINE; NALOXONE; NF-KAPPA B; PIPERIDINES; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTORS, CCR2; SUBSTANCE WITHDRAWAL SYNDROME; THIOCARBAMATES;

EID: 84858436454     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-011-2489-8     Document Type: Article

References (50)

1. Akil H, Lewis JW (1987) Neurotransmitters and pain control, vol 9. Pain and headache. Karger, Basel, pp 129-159
2. Allavena P, Bianchi G, Zhou D, Van DJ, Jilek P, Sozzani S, Mantovani A (1994) Induction of natural killer cell migration by monocyte chemotactic protein-1, -2 and -3. Eur J Immunol 24:3233-3236
3. Avdoshina V, Biggio F, Palchik G, Campbell LA, Mocchetti I (2010) Morphine induces the release of CCL5 from astrocytes: potential neuroprotective mechanism against the HIV protein gp120. Glia 58(13):1630-1639
4. Baeuerle PA (1991) The inducible transcription activator NF-KB: regulation by distinct protein subunits. Biochim Biophys Acta 1072:63-80 (Pubitemid 121007530)
5. Banisadr G, Gosselin RD, Mechighel P, Rostene W, Kitabgi P, Melik PS (2005) Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons. J Comp Neurol 492:178-192 (Pubitemid 41443720)
6. Boddeke EW, Meigel I, Frentzel S, Gourmala NG, Harrison JK, Buttini M, Spleiss O, Gebicke-Harter P (1999) Cultured rat microglia express functional beta-chemokine receptors. J Neuroimmunol 98:176-184 (Pubitemid 29317544)
7. Capasso A (2001) Involvement of nuclear factor-kB in the expression of opiate withdrawal. Prog Neuropsychopharmacol Biol Psychiatry 25:1259-1268 (Pubitemid 32835283)
8. Capasso A, Gallo A (2009) Molecules acting on CB1 receptor and their effects on morphine withdrawal in vitro. Open Biochem J 3:78-84
9. Capasso A, Sorrentino L (1997) Differential influence of D1 and D2 dopamine receptors on acute opiate withdrawal in guinea-pig isolated ileum. Br J Pharmacol 120:1001-1006 (Pubitemid 27122636)
10. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA (1994) Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 91:3652-3656 (Pubitemid 24139489)
11. Chen YL, Law PY, Loh HH (2006) Nuclear factor kappaB signaling in opioid functions and receptor gene expression. J Neuroimmun Pharmacol 1(3):270-279 (Pubitemid 44244132)
12. Conant K, Garzino-Demo A, Nath A, McArthur JC, Halliday W, Power C, Gallo RC, Major EO (1998) Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 95:3117-3121 (Pubitemid 28135864)
13. D'Amour FE, Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74
14. Dorf ME, Berman MA, Tanabe S, Heesen M, Luo Y (2000) Astrocytes express functional chemokine receptors. J Neuro-immunol 111:109-121
15. El-Hage N, Wu G, Ambati J, Bruce-Keller AJ, Knapp PE, Hauser KF (2006) CCR2 mediates increases in glial activation caused by exposure to HIV-1 Tat and opiates. J Neuroimmunol 178(1-2):9-16 (Pubitemid 44307341)
16. Falls WA, Kelsey JE (1989) Procedures that produce context-specific tolerance to morphine in rats also produce context-specific withdrawal. Behav Neurosci 103:842-849 (Pubitemid 19218417)
17. Galasso JM, Miller MJ, Cowell RM, Harrison JK, Warren JS, Silverstein FS (2000) Acute excitotoxic injury induces expression of monocyte chemoattractant protein-1 and its receptor, CCR2, in neonatal rat brain. Exp Neurol 165:295-305
18. Georgescu D, Zachariou V, Barrot M, Mieda M, Willie JT, Eisch AJ, Yanagisawa M, Nestler EJ, DiLeone RJ (2003) Involvement of the lateral hypothalamic peptide orexin in morphine dependence and withdrawal. J Neurosci 23:3106-3111 (Pubitemid 36531950)
19. Glick SD, Morihisa JM (1976) Changes in sensitivity of morphine-induced circling behaviour after chronic treatment and persistence after withdrawal in rats. Nature 260:159-161
20. Guerrini L, Blasi F, Donini SD (1976) Synaptic activation of NF-KB by glutamate in cerebellar granule neurons in vitro. Proc Natl Acad Sci USA 92:9077-9081
21. Hardman JG, Limbird LE, Gilman AG (2001) Goodman and Gilman's The pharmacological basis of therapeutics. McGraw Hill, New York
22. Inoue M, Mishina M, Ueda H (2003) Locus specific rescue of GluR-1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J Neurosci 23:6529-6536 (Pubitemid 36909879)
23. Kaltschmidt B, Kaltschmidt C (2009) NF-kB in the nervous system. Cold Spring Harb Perspect Biol 1:a001271
24. Kelder W, McArthur JC, Nance-Sproson T, McClernon D, Griffin DE (1998) Beta-chemokines MCP-1 and RANTES are selectively increased in cerebrospinal fluid of patients with human immunodeficiency virus-associated dementia. Ann Neurol 44:831-835 (Pubitemid 28516058)
25. Krantz MJ, Mehler PS (2004) Treating opioid dependence growing implications for primary care. Arch Intern Med 164:277-288 (Pubitemid 38180528)
26. Liu Z, Zheng JF, Yang LQ, Yi L, Hu B (2007) Effects of sinomenine on NO/nNOS system in cerebellum and spinal cord of morphine-dependent and withdrawal mice. Sheng Li Xue Bao 59:285-292
27. Marshall J, Graham-Smith DG (1971) Evidence against a role of brain 5-hydroxytryptamine in the development of physical dependence upon morphine in mice. J Pharmacol Exp Ther 173:634-641
28. Matsushima K, Larsen CG, DuBois GC, Oppenheim JJ (1989) Purification and characterization of a novel monocyte chemotactic and activating factor produced by a human myelomonocytic cell line. J Exp Med 169:1485-1490 (Pubitemid 19104979)
29. McManus C, Berman JW, Brett FM, Staunton H, Farrell M, Brosnan CF (1998) MCP-1, MCP-2 and MCP-3 expression in multiple sclerosis lesions: an immunohistochemical and in situ hybridization study. J Neuroimmunol 86:20-29 (Pubitemid 28293946)
30. Mirzadegan T, Diehl F, Ebi B, Bhakta S, Polsky I, McCarley D, Mulkins M, Weatherhead GS, Lapierre JM, Dankwardt J, Morgans D Jr, Wilhelm R, Jarnagin K (2000) Identification of the binding site for a novel class of CCR2b chemokine receptor antagonists. J Biol Chem 275:25562-25571
31. Mundey MK, Mason R, Wilson VG (1998) Selective potentiation by ouabain of naloxone-induced withdrawal contractions of isolated guinea-pig ileum following acute exposure to morphine. Br J Pharmacol 124:911-916 (Pubitemid 28312825)
32. O'Neill LA, Kaltschmidt C (1997) NF-kappa B: a crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20:252-258 (Pubitemid 27261456)
33. Onuffer JJ, Horuk R (2002) Chemokines, chemokine receptors and small-molecule antagonists: recent developments. Trends in Pharm Sci 23:459-467 (Pubitemid 35279607)
34. Palma-Nicolás JP, López E, López-Colomé AM (2010) Thrombin stimulates RPE cell motility by PKC-zeta- and NF-kappaB-dependent gene expression of MCP-1 and CINC-1/GRO chemokines. J Cell Biochem 110(4):948-967
35. Patkina NA, Zvartau EE (1978) Rat behavior in an "open field" when chronically administered morphine. Farmakol Toksikol 41:537-541 (Pubitemid 9010212)
36. Reddy DS, Kulkarni SK (1998) Possible role of nitric oxide in the nootropic and antiamnesic effects of neurosteroids on aging and dizocilpine-induced learning impairment. Brain Res 799:215-229 (Pubitemid 28351250)
37. Rehni AK, Singh N (2011) Modulation of src-kinase attenuates naloxone-precipitated opioid withdrawal syndrome in mice. Behav Pharmacol 22(2):182-190
38. Rehni AK Bhateja P, Singh TG, Singh N (2008a) Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Behav Pharmacol 19(3):265-269 (Pubitemid 351670407)
39. Rehni AK, Singh I, Singh N, Bansal N, Bansal S, Kumar M (2008b) Pharmacological modulation of leukotriene D(4) attenuates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Eur J Pharmacol 598(1-3):51-56
40. Rock RB, Hu S, Sheng WS, Peterson PK (2006) Morphine stimulates CCL2 production by human neurons. J Neuroinflammation 3:32
41. Schreck R, Meier B, Männel DN, Dröge W, Baeuerle PA (1992) Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J Exp Med 175:1181-1194
42. Sokolova A, Hill MD, Rahimi F, Warden LA, Halliday GM, Shepherd CE (2009) Monocyte chemoattractant protein-1 plays a dominantrole in the chronic inflammation observed in Alzheimer's disease. Brain Pathol 19:392-398
43. Tallarida RJ, Porreca F, Cowan A (1989) Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci 45:947-961 (Pubitemid 19251921)
44. Trujillo KA, Akil H (1995) Excitatory amino acids and drugs of abuse: a role for N-methyl-D-aspartate receptors in drug tolerance, sensitization and physical dependence. Drug Alcohol Depend 38:139-154
45. Valeri P, Morrone LA, Romanelli L, Amico MC (1995) Acute withdrawal after bremazocine and the interaction between p-and ic-opioid receptors in isolated gut tissues. Br J Pharmacol 114:1206-1210
46. Van Ree JM, Gerrits MAFM, Vanderschuren LJMJ (1999) Opioids, reward and addiction: an encounter of biology, psychology, and medicine. Pharmacol Rev 51:341-396 (Pubitemid 29269983)
47. Way EL, Loh HH, Shen FH (1969) Simultaneous quantitative assessment of morphine tolerance and physical dependence. J Pharmacol Exp Ther 167:1-8
48. White F, Wilson N (2010) Opiate-induced hypernociception and chemokine receptors. Neuropharmacology 58(1):35-37
49. Williams JT, Christie MJ, Manzoni O (2001) Cellular and synaptic adaptations mediating opioid dependence. Physiol Rev 81:299-343 (Pubitemid 32096178)
50. Wu Y, Wang X, Mo X, Xi Z, Xiao F, Li J, Zhu X, Luan G, Wang Y, Li Y et al (2008) Expression of monocyte chemoattractant protein-1 in brain tissue of patients with intractable epilepsy. Clin Neuropathol 27:55-63 (Pubitemid 351428575)